Keros Therapeutics, Inc. Made Big Gain

Keros Therapeutics, Inc. (KROS:NASDAQ) jumped higher at $53.08, representing a gain of 27.7%. On Wed, Nov 03, 2021, KROS:NASDAQ hit a New 2-Week Intraday High of $42.92. The stock appeared on our News Catalysts scanner on Thu, Nov 04, 2021 at 10:15 AM in the 'EARNINGS' category. From Wed, Oct 20, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days

The share price of the company has been moving sideways in recent weeks.

About Keros Therapeutics, Inc. (KROS:NASDAQ)

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.